Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,382 public trials 2,843 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia

NCT05599880

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Seoul National University Bundang Hospital Guri-si, South Korea

Seoul National University Hospital Seoul, South Korea

SMG-SNU Boramae Medical Center Seoul, South Korea

Seoul National University Hospital Seoul, South Korea

View Trial Details

Recruiting

Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders

NCT03579875

Conditions: Anemia, Anemia, Aplastic, Anemia, Hypoplastic, Congenital, +24 more
Locations: Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States

View Trial Details

Recruiting

This Study is a FIH Study Which is Required to Understand the PK Characteristics, MTD, RP2D and Safety Profile.

NCT06756451

Conditions: Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
Locations: The First Affiliated Hospital of USTC Hefei, Anhui, China

The Second Hospital of Anhui Medical University Hefei, Anhui, China

Guangdong Provincial People's Hospital Guangzhou, Guangdong, China

Southern Medical University Nanfang Hospital Guangzhou, Guangdong, China

View all 16 locations

View Trial Details

Recruiting

Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT

NCT05917405

Conditions: Acute Myeloid Leukemia in Remission, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: CHU de Nantes Nantes, Loire Atlantique, France

CHU Amiens Amiens, France

CHU Angers Angers, France

CHU Besançon Besançon, France

View all 23 locations

View Trial Details

Recruiting

Sepsis-associated Thrombocytopenia and Platelet Transfusion （STAPT）

NCT07230067

Conditions: Cardiovascular Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Nanfang Hospital， Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients

NCT07372170

Conditions: Antiphospholipid Syndrome, Antiphospholipid Syndrome (APS), Autoimmune Diseases, +10 more
Locations: Hospital Universitario Infanta Leonor Madrid, Spain

Hospital Universitario Infanta Sofía Madrid, Spain

View Trial Details

Recruiting

Amish/Mennonite Research Contact Registry

NCT02990572

Conditions: ALL, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

NCT07297329

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Beijing Chaoyang Hospital affiliated to Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Recruiting

MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease

NCT06853158

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations: UH Seidman Cancer Center Adult SCD Clinic or UH Rainbow Babies and Children's Hospital Sickle Cell Anemia Center Cleveland, Ohio, United States

Prisma Health Lifespan Comprehensive SCD Program Greenville, South Carolina, United States

View Trial Details

Recruiting

Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency

NCT04240054

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Female Urogenital Diseases, +19 more
Locations: Froedtert Hospital & the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions